Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Twist Bioscience Corporation

< Previous 1 2 3 4 5 6 Next >
Twist Bioscience Enters into Definitive Agreement to Acquire Abveris, Bolstering Biopharma Capabilities
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Expands Partnership with Invetx to Include Discovery of Best-in-Class Antibodies to Treat Multiple Diseases in Cats and Dogs
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Launches Revelar Biotherapeutics to Develop and Commercialize Novel COVID-19 and Other Antibody Therapeutics for Difficult to Treat Diseases
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience to Present at the Stifel 2021 Virtual Healthcare Conference
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Named in Inc.’s First Annual Best-Led Companies List
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience to Report Fiscal 2021 Fourth Quarter and Full Year Financial Results on Monday, November 22, 2021
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Launches Exome 2.0 for Genomics Research
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience and the Broad Institute Create Custom Whole Exome Target Enrichment Panel for Clinical Research
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Appoints Steffen Hellmold as Senior Vice President, Business Development, Data Storage
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience and CENTOGENE to Develop Advanced Sequencing Tools to Make Genetic Testing Rapidly Accessible for More Patients With Rare Diseases
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Expands Expert Custom Alliance Panel Offering
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Internally-Discovered Single Domain Antibody TB202-3 Shows Potent Binding to Multiple Strains of SARS-CoV-2, Including Alpha, Beta, and Gamma Strains, in Preclinical Studies
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Collaborates with Deep Learning Experts deepCDR on Antibody Library Design
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Continues Commitment to Deliver Synthetic RNA Controls, now to Fight Delta Plus Variants of COVID-19
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Boehringer Ingelheim and Twist Bioscience Enter Therapeutic Antibody Discovery Collaboration
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience to Present at Baird 2021 Global Healthcare Conference
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience to Present at UBS Genomics 2.0 and Medtech Innovations Summit
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Reports Third Quarter Fiscal 2021 Financial Results
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Appoints Drug Discovery Leader Melissa Starovasnik, Ph.D., to Board of Directors
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Incorporates MOLCURE AI Technology to Augment Therapeutic Antibody Discovery
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Now Shipping Synthetic RNA Positive Controls for Delta (B.1.617.2) SARS-CoV-2 Variant for Development of Accurate Diagnostic Tests
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience to Report Fiscal 2021 Third Quarter Financial Results on Friday, August 6, 2021
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Acquires NGS Library Preparation Maker iGenomX
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Collaborates with Regeneron for Production of Genotyping by Sequencing Panel to Enable Diverse Genome-wide Screening
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Announces Fireside Chat and Presentation at BIO Digital
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
DNA Data Storage Alliance Publishes First White Paper, Launches Website
From Twist Bioscience Corporation
Via Business Wire
Tickers ILMN TWST WDC
Twist Bioscience Begins Shipping of Synthetic RNA Controls for Kappa (B.1.617.1) SARS-CoV-2 Variants for Development of Accurate Tests
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Launches Enzymatic Fragmentation Library Preparation Kit for High Uniformity, High-Yield Amplification, Streamlined Next Generation Sequencing Workflow for Targeted Applications
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience to Present at Upcoming Virtual Conferences
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Supports the Engineering Biology Research Consortium as it Publishes Statement of Ethics
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.